Physician profile
Patrick L Brau
NPI 1760052906
$586.75
in general payments reported to CMS, 2019-2025
15 companies · $494 in 2025
The $494 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $14.34 · 2024: $78.72 · 2025: $494.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $587.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $586.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $184.59 | 2024-2025 | |
| Lilly USA, LLC | $81.54 | 2025 | Mounjaro, Zepbound |
| Amgen INC. | $70.11 | 2024-2025 | Evenity, Prolia |
| Novo Nordisk INC | $65.22 | 2024-2025 | Ozempic, Rybelsus |
| Viatris Specialty LLC | $28.46 | 2025 | Yupelri |
| Mylan Specialty L.P. | $19.38 | 2024 | Yupelri |
| Phathom Pharmaceuticals, INC. | $18.81 | 2025 | Voquezna |
| Inspire Medical Systems, INC. | $17.35 | 2025 | Inspire |
| Insmed, INC. | $16.63 | 2025 | Arikayce |
| Takeda Pharmaceuticals U.S.A., INC. | $14.46 | 2025 | Glassia |
| Organon LLC | $14.34 | 2023 | Nexplanon |
| Actelion Pharmaceuticals US, INC. | $14.21 | 2025 | Opsumit, Uptravi |
| Dexcom, INC. | $14.17 | 2025 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $14.01 | 2025 | |
| Abbott Laboratories | $13.47 | 2025 | Freestyle Libre 3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Brau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.